Drupal.behaviors.print = function(context) {window.print();window.close();}>
MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx
May 09, 2012
MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
MDx/CDx Focus: Phase III Adcetris Trial in Hodgkin Lymphoma; FDA Priority Review for Roche's T-DM1
November 7, 2012 / Pharmacogenomics Reporter
CAP Accredits CardioDx's Laboratory
May 9, 2013 / GenomeWeb Daily News
CardioDx Says $58M Financing Will Support Commercial Expansion Following Medicare Coverage Win
August 29, 2012 / Pharmacogenomics Reporter
Ventana Developing CDx for Seattle Genetics, Millenium Cancer Drug
April 12, 2012 / GenomeWeb Daily News
CardioDx to Use $60M Funding Round to Make Clinical Utility Case for Corus CAD
May 18, 2011 / Pharmacogenomics Reporter